• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Chronic Graft Versus Host Disease

Chronic Graft Versus Host Disease - 29 Studies Found

Completed : Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)
: Chronic Graft Versus Host Disease
: 2016-02-24
:
  • Drug: Entospletinib Entospleti

Active, not recruiting : Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
: Chronic Graft-versus-host Disease
: 2011-06-02
: Drug: Interleukin-2 Daily subcutaneous IL-2 (1 x 10^6 IU/m^2/day) for self-administration for 12 weeks f
Completed : Evaluation of the Diagnostic Value of PET (18F-FDG) in Chronic Graft Versus Host Disease (cGVH)
: Chronic Graft Versus Host Disease
: 2015-01-23
: Procedure: PET (18-FDG) Every patient will have a PET
Completed : Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease
: Chronic Graft Versus Host Disease
: 2008-12-30
:
  • Drug: bortezomib Given intrave

Suspended : Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host Disease
: Chronic Graft-Versus-Host-Disease
: 2009-12-18
Terminated : Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease
: Chronic Graft-versus-host Disease
: 2010-10-21
: Drug: Alefacept Given intravenously Days 1 and 4 of Week 1, then subcutaneously once weekly for Weeks 2-
Recruiting : A Phase I Study of Abatacept in the Treatment of Patients With Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)
: Chronic Graft Versus Host Disease
: 2013-09-27
: Drug: Abatacept The study will follow a standard 3+3 design with two escalating doses of abatacept to de
Active, not recruiting : Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-host Disease With Prednisone and Everolimus
: Chronic Graft-versus-host Disease
: 2013-05-01
: Drug: PredEver Firstline treatment with prednisone and Everolimus
Completed : Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease
: Chronic Graft Versus Host Disease
: 2015-11-23
:
  • Biological: Aldesleukin Given

Completed : Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease
: Chronic Graft Versus Host Disease
: 2012-02-01
:
  • Biological: Biological: mesenchymal stem cell

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.